Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis

Vincent W. Yang, Janiel M. Shields, Stanley R. Hamilton, Ernst W. Spannhake, Walter C. Hubbard, Linda M. Hylind, C. Rahj Robinson, Francis M. Giardiello

Research output: Contribution to journalArticlepeer-review

Abstract

Recent studies indicate that nonsteroidal anti-inflammatory drugs have a chemopreventive effect against colorectal neoplasia. Nonsteroidal anti- inflammatory drugs inhibit cyclooxygenases, principal enzymes that mediate the formation of prostanoids. To determine whether prostanoids are involved in the pathogenesis of colorectal adenomas, we compared the levels of five major stable metabolic products of the cyclooxygenase pathway in the normal- appealing mucosa and in adenomas of patients with familial adenomatosis polyposis. Of 12 patients tested, 6 had elevated levels of at least one prostanoid in the adenomas. More importantly, the relative levels of three prostanoids [prostaglandin (PG)D2, PGE2, and 6-keto-PGF(1α)] were elevated in adenomas compared to normal-appearing mucosa from the same patients, and the resulting ratios were correlated with the size of the adenoma. These results suggest a role for prostanoids in progression of colorectal polyposis in familial adenomatosis polyposis patients.

Original languageEnglish (US)
Pages (from-to)1750-1753
Number of pages4
JournalCancer Research
Volume58
Issue number8
StatePublished - Apr 15 1998

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis'. Together they form a unique fingerprint.

Cite this